ArticleHuman genetics2007
Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variation.
Article in Human genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 54 citations in OpenAlex.
- A Genome-Wide Pharmacogenetic Study of Growth Hormone Responsiveness.The Journal of clinical endocrinology and metabolism · 2020Observational
- A descriptive study on selected growth parameters and growth hormone receptor gene in healthy young adults from the American Midwest.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2018Article
- Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature.Journal of cellular and molecular medicine · 2017Article
- The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness.The pharmacogenomics journal · 2016Article
- Rapid method for growth hormone receptor exon 3 delete (GHRd3) SNP genotyping from archival human placental samples.Endocrine · 2015Article
- The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.Clinical epigenetics · 2015Article
- Epigenetic heredity of human height.Physiological reports · 2014Article
- The exon 3 polymorphism of the growth hormone receptor is a severity-related factor for osteoporosis.Endocrine · 2014Article
- Towards identification of molecular mechanisms of short stature.International journal of pediatric endocrinology · 2013Article
- Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.The pharmacogenomics journal · 2012Article
- Genetic variability in IGF-1 and IGFBP-3 and body size in early life.BMC public health · 2012Article
- A multi-cohort study of polymorphisms in the GH/IGF axis and physical capability: the HALCyon programme.PloS one · 2012Article
- The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions.Journal of endocrinological investigation · 2011Review
- Article
- Genome-wide association of anthropometric traits in African- and African-derived populations.Human molecular genetics · 2010Article
- Genome-wide association study of height and body mass index in Australian twin families.Twin research and human genetics : the official journal of the International Society for Twin Studies · 2010Article
- Extended haplotypes in the growth hormone releasing hormone receptor gene (GHRHR) are associated with normal variation in height.PloS one · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Stature (adult height) is one of the most heritable human traits, yet few genes, if any, have been convincingly associated with adult height variation in the general population. Here, we selected 150 tag SNPs from eight candidate genes in the growth hormone (GH)/insulin-like growth factor-1 (IGF1) axis (GHR, GHRH, GHRHR, IGF1, IGFALS, IGFBP3, JAK2, STAT5B), and genotyped them in approximately 2,200 individuals ascertained for short or tall stature. Nominally significant tag SNPs were then tested in three additional replication cohorts, including a family-based panel to rule out spurious associations owing to population stratification. Across the four height cohorts (N = 6,075 individuals), we did not observe any consistent associations between stature and common variants (> or =5% minor allele frequency) in these eight genes, including a common deletion of the growth hormone receptor gene exon 3. Tests of epistatic interactions between these genes did not yield any results beyond those expected by chance. Although we have not tested all genes in the GH/IGF1 axis, our results indicate that common variation in these GH/IGF1 axis genes is not a major determinant of stature, and suggest that if common variation contributes to adult height variation in the general population, the variants are in other, possibly unanticipated genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.